HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

High-dose immunoglobulin for juvenile myasthenia gravis.

Abstract
A four-year-old girl with the ocular type of myasthenia gravis was effectively treated with intravenous high dose human immunoglobulin. Since conventional anti-choline-esterase drugs failed to induce a satisfactory outcome and the patient continued to suffer from amblyopia, high-dose immunoglobulin was tried according to the method of Gados. Subsequently, she became asymptomatic and her anti-acetylcholine-receptor antibody titer decreased gradually to normal. Currently, she is six years old and continues to be free from complaints and on no medication.
AuthorsY Maruyama, S Takeshita, I Sekine, S Yoshioka
JournalActa paediatrica Japonica; Overseas edition (Acta Paediatr Jpn) Vol. 31 Issue 5 Pg. 544-8 (Oct 1989) ISSN: 0374-5600 [Print] JAPAN
PMID2515731 (Publication Type: Case Reports, Journal Article)
Topics
  • Blepharoptosis (etiology)
  • Child, Preschool
  • Female
  • Humans
  • Immunization, Passive
  • Myasthenia Gravis (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: